Document Detail


Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls.
MedLine Citation:
PMID:  19272798     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: We previously published research on 4- and 8-year follow-ups of patient-reported sexual function after conventional external beam radiotherapy (EBRT) for localized prostate cancer (LPC) compared with age-matched controls. The current study is a prolonged 15-year follow-up with the same cohorts.
MATERIAL AND METHODS: The cohort consisted of 29 men surviving from a group of 181 men treated between 1986 and 1989, and who were reported on previously. Of the originally reported 141 controls, 62 were eligible and 34 completed the questionnaires. Sexual function was assessed using two questionnaires, Prostate Cancer Symptom Scale (PCSS) and International Index of Erectile Function (IIEF-5).
RESULTS: Twenty-three patients (78%) and 13 controls (38%) were not sexually active. None of the patients and 14 controls had enough of an erection to perform intercourse. Seventeen patients (94%) and 14 controls (64%) had severe erectile dysfunction. Patients with clinical progression and who had received hormone treatment had decreased sexual desire. No significant differences were measured between patients without progression/hormone treatment and the controls.
CONCLUSION: The sexual activity 15 years after EBRT for LPC was very low, as was the probability of achieving an erection. Patients with a progressive disease and treated with hormones reported worse sexual and erectile function. The LPC free men showed higher sexual activity, lower sexual bother, and better erectile function than the patients.
Authors:
Per Fransson; Anders Widmark
Related Documents :
21081568 - The use of joint-specific and whole-body mri in osteonecrosis: a study in patients with...
6956758 - Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recur...
21552998 - Natural history and progression factors of unilateral moyamoya disease in pediatric pat...
3568048 - The importance of creatine kinase determination in identifying acute myocardial infarct...
12215828 - Utility of computed tomographic renal angiogram in the management of childhood hyperten...
11095048 - The role of glaucoma therapy in the need for repeat penetrating keratoplasty.
Publication Detail:
Type:  Journal Article     Date:  2009-03-09
Journal Detail:
Title:  Urologic oncology     Volume:  29     ISSN:  1873-2496     ISO Abbreviation:  Urol. Oncol.     Publication Date:    2011 Mar-Apr
Date Detail:
Created Date:  2011-03-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805460     Medline TA:  Urol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  137-44     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hormonal and pathologic changes after chemoablation of testes with hypertonic saline solution as a t...
Next Document:  Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.